Golden Recursion Inc. logoGolden Recursion Inc. logo
Advanced Search
Cepheid Inc

Cepheid Inc

Cepheid Inc. is a molecular diagnostics company that looks to provide molecular systems and tests for genetic-bases diseases as well as organism based diseases.

Cepheid Inc. is a molecular diagnostics company that looks to provide molecular systems and tests for genetic-bases diseases as well as organism based diseases. The company was founded by Allen Northrup, Dennis Giesing, and Steve Young, in 1996, in Sunnyvale, California, United States.

The company looks to provide a molecular platform for healthcare leaders, institutions, medical clinics, laboratories, and hospitals. Their tests cover various clinical applications including healthcare-associated infections, sexual health, critical infectious disease, virology, and oncology.

COVID-19

Since the outbreak of COVID-19 (coronavirus), Cepheid has partnered with Sherlock Biosciences to develop a concept project that detects SARS-CoV-2 coronavirus as a first initiative of a broader collaboration to developing molecular diagnostic tests for infectious diseases and oncology. The molecular test will use CRISPR technology and the SHERLOCK platform.

Their collaboration looks to pursue a broad set of solutions for clinical and non-clinical coronavirus solutions. The company looks to deal with infections, critical and non-critical, and oncology that is associated with coronavirus. The company has also partnered with GeneXpert to find solutions for diseases.

On March 21, received emergency use authorization from the FDA for a COVID-19 test. The test is a PCR test that runs in 45 minutes and uses a cartridge and is run on Cepheid’s GeneXpert Systems. The automated systems do not require users to have special training and there is less than a minute of hands on time. There are 23,000 GeneXpert Systems worldwide and 5000 in the US.

Timeline

Funding rounds

Patents

Further Resources

Title
Author
Link
Type
Date

Cepheid | About Us

Web

Cepheid | Enabling Access to Molecular Diagnostic Testing Everywhere

Web

Cepheid, Sherlock to Develop Coronavirus Test, Part of Broader MDx Collaboration

Web

March 2, 2020

Review of use of a new rapid real-time PCR, the Cepheid GeneXpert® (Xpert) CT/NG assay, for Chlamydia trachomatis and Neisseria gonorrhoeae: result... - PubMed - NCBI

pubmeddev, Gaydos CA

Web

References

Golden logo
By using this site, you agree to our Terms & Conditions.